TickerFacts.

C21 Investments Inc. (CWLXF): Cost of Revenue

Annual figures by period end, from SEC filings.

$19.01M
Year ended 2026-03-31
2021-01-31: $15.42M2022-01-31: $14.17M2023-01-31: $15.49M2024-01-31: $17.14M2025-03-31: $17.56M2026-03-31: $19.01M$19.01M
2021-01-31 Cost of Revenue (USD) 2026-03-31
Period endedCost of RevenueChange YoYSource filing
2026-03-31$19.01M+8.3%2026-06-12, From 2025-04-01
2025-03-31$17.56Mn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31$17.14M+10.6%2025-06-23, From 2023-02-01
2023-01-31$15.49M+9.3%2024-08-08, From 2022-02-01
2022-01-31$14.17M-8.1%2023-07-28, From 2021-02-01
2021-01-31$15.42Mn/a2023-07-28, From 2020-02-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$19.01M+8.3%
Leef Brands Inc. (LEEEF)2025-12-31$24.30M+16.8%
Synergy CHC Corp. (SNYRQ)2025-12-31$10.08M-9.9%
Cyanotech Corp (CYAN)2025-03-31$17.34M+1.2%
Charlie's Holdings, Inc. (CHUC)2025-12-31$15.26M+212.2%
Bon Natural Life Ltd (BON)2025-09-30$14.79M-11.6%
Fitlife Brands, Inc. (FTLF)2025-12-31$50.01M+37.4%
Mannatech Inc (MTEX)2025-12-31$27.08M+2.5%
Niagen Bioscience, Inc. (NAGE)2025-12-31$46.23M+21.6%

Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗